ESH-ICMLF 13th International Conference Chronic Myeloid Leukemia: Biological Basis of Therapy

- , Estoril

Pozvání na událost

Hlavní tematické sekce

  • LEUKEMIA + HSC BIOLOGY AND NOVEL THERAPEUTIC APPROACHES FOR CML ERADICATION
  • GENETICS, BIOLOGY AND POSSIBLE THERAPIES FOR CML IN BLASTIC TRANSFORMATION
  • ALTERNATIVE AVENUES TO TARGET CML STEM/PROGENITOR CELLS
  • GENOMIC INSTABILITY AND GENETICS OF CML
  • ABL TYROSINE KINASE INHIBITORS (1): BIOLOGY AND RESISTANCE
  • IMMUNOLOGICAL TARGETS AND MONITORING AT LOW LEUKEMIA LEVEL
  • ABL TYROSINE KINASE INHIBITORS (2): BIOLOGY AND RESISTANCE
  • CML CLINICAL ASPECTS AND NEW TRIALS
  • MINI-DEBATES: TOPICAL BIOLOGICAL QUESTIONS
  • MINI-DEBATE: TOPICAL CLINICAL QUESTIONS

Aktivní účast

  • Abstrakta do 10. července 2011

Registrace

  • Přidat do kalendáře: 2011-09-22 00:00:00 2011-09-25 23:59:59 Europe/Prague ESH-ICMLF 13th International Conference Chronic Myeloid Leukemia: Biological Basis of Therapy Hlavní tematické sekce LEUKEMIA + HSC BIOLOGY AND NOVEL THERAPEUTIC APPROACHES FOR CML ERADICATION GENETICS, BIOLOGY AND POSSIBLE THERAPIES FOR CML IN BLASTIC TRANSFORMATION ALTERNATIVE AVENUES TO TARGET CML STEM/PROGENITOR CELLS GENOMIC INSTABILITY AND GENETICS OF CML ABL TYROSINE KINASE INHIBITORS (1): BIOLOGY AND RESISTANCE IMMUNOLOGICAL TARGETS AND MONITORING AT LOW LEUKEMIA LEVEL ABL TYROSINE KINASE INHIBITORS (2): BIOLOGY AND RESISTANCE CML CLINICAL ASPECTS AND NEW TRIALS MINI-DEBATES: TOPICAL BIOLOGICAL QUESTIONS MINI-DEBATE: TOPICAL CLINICAL QUESTIONS Estoril